U.S. market Closed. Opens in 2 hours 37 minutes

DMAC | DiaMedica Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
RevenueN/AN/AN/AN/AN/A500.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A160.62K25.74K25.68K33.88K
Cost of Revenue30.00K25.00K24.00K21.00K21.00KN/A4.00K2.21K4.46KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-30.00K-25.00K-24.00K-21.00K-21.00K500.00K-4.00K-2.21K-4.46KN/AN/AN/AN/AN/AN/AN/A160.62K25.74K25.68K33.88K
Operating Expenses21.27M14.00M13.65M12.49M10.74M6.05M4.28M2.48M1.31M4.83M7.43M10.11M6.71M3.84M2.40M1.69M2.47M812.95K228.69K637.31K
Selling, General & Admin8.16M6.16M4.88M4.39M3.69M2.74M1.31M718.04K423.35K1.12M2.54M2.53M2.08M1.30M1.00M618.54K1.38M192.37K177.78K168.91K
Research & Development13.11M7.84M8.77M8.31M7.90M4.52M3.21M1.76M886.07K3.71M3.78M5.21M2.33M803.98K1.37M1.04M1.07M617.26K22.75K462.00K
Other Operating ExpensesN/A353.00K82.00K-205.00K-856.00K-68.00K6.00K221.90K3.00KN/AN/AN/AN/AN/A6.58K-4.89KN/AN/AN/AN/A
Operating Income-21.27M-14.00M-13.65M-12.70M-11.59M-6.76M-4.52M-2.48M-1.31M-4.83M-7.43M-10.11M-6.71M-3.84M-2.40M-1.69M-2.31M-787.21K-203.01K-603.43K
Other Expenses / Income1.93M353.00K82.00K434.00K975.00K747.00K259.00K280.63K-104.38K-185.41K-230.99K37.57K-174.26K-422.84K101.28K-168.32K57.19K-12.38K10.28K66.55K
Before Tax Income-19.34M-13.65M-13.56M-12.27M-10.62M-5.65M-4.26M-2.20M-1.43M-4.78M-7.41M-10.05M-6.61M-4.27M-2.44M-1.85M-2.31MN/A-192.73K-570.16K
Income Tax Expenses43.00K28.00K28.00K27.00K31.00K80.00K-9.00K22.31K12.45K42.28K7.73K2.71K12.57K499.08K41.69K163.43K20.20K-9.19K17.87K69.86K
Net Income-19.38M-13.68M-13.59M-12.29M-10.65M-5.73M-4.26M-2.22M-1.44M-4.82M-7.41M-10.05M-6.61M-4.27M-2.44M-1.85M-2.33M-778.02K-210.60K-640.02K
Interest ExpensesN/AN/AN/AN/AN/AN/AN/A48.38K43.95KN/A7.73K2.71K12.57KN/AN/AN/AN/AN/A7.59K36.59K
Basic Shares Outstanding32.57M26.44M20.77M15.68M11.99M7.74M5.94M4.74M3.62M3.11M2.73M2.45M2.26M1.43M960.48K909.72K802.30K876.03K420.15K272.16K
Diluted Shares Outstanding32.57M26.44M20.77M15.68M11.99M7.74M5.94M4.74M3.62M3.11M2.73M2.45M2.26M1.43M960.48K909.72K802.30K876.03K420.15K272.16K
EBITDA-19.31M-13.98M-13.62M-12.24M-10.60M-5.64M-4.26M-2.15M-1.50M-5.01M-6.51M-7.70M-4.51M-3.32M-2.27M-2.34M-2.29M-783.89K-190.25K-630.30K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%-1,127.80%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,426.62%-3,045.78%-740.90%-1,860.33%
EBIT-19.34M-13.65M-13.56M-12.27M-10.62M-5.65M-4.27M-2.15M-1.39M-4.78M-7.40M-10.05M-6.58M-3.77M-2.39M-1.69M-2.31M-787.21K-185.13K-533.57K
EBIT Margin0.00%0.00%0.00%0.00%0.00%-1,130.80%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-1,440.21%-3,058.67%-720.96%-1,574.84%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙